Skip to main content
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter August 2019

News: Gene Therapy Making Waves for Lung Cancer Patients
The development of lung cancer treatment have come a long way within the last decade. The progression of gene therapy through clinical trials is contributing to millions of lives extended as well as more patients going into remission. The success gene therapy is playing towards these common cancers are making waves in the rare space as well. An uncommon cancer affecting the lungs- mesothelioma, will hopefully start to leverage these types of treatments in the near future.

SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
Evaluating the Key Challenges to Advance Commercialisation & Patient Access. SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15-16 October 2019 in London, UK.

The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerate orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.

Find our more and register at a discounted rate at

Gene Therapy for Rare Disorders Europe
The Gene Therapy for Rare Disorders Europe, 15-17 October 2019 in London, UK, is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.

Rather than early stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward.

Access the official agenda for more information.

NORD’s Rare Diseases & Orphan Products Breakthrough Summit
At the largest and most impactful rare disease conference of the year, NORD’s Rare Diseases & Orphan Products Breakthrough Summit, 21-22 October 2019 in Washington, DC, the heads of FDA, CDER, CBER and CDRH will share their insights on current issues including Patient-Focused Drug Development, gene therapy, pediatric drugs and devices, natural history studies and more. Attendees can take the unique opportunity to ask questions directly of FDA senior staff during a special town hall conversation. The Summit offers numerous networking opportunities with 95+ speakers, 6 break out sessions, leaders from multiple stakeholder groups, expansive poster sessions, roundtable discussions and much more.

Register now.

Neuromuscular Drug Development Summit
The Neuromuscular Drug Development Summit, 23-25 October 2019 in Boston, will gather together over 60 leading drug developers and decision makers in the CNS field to overcome the translational challenges of developing efficacious therapeutics to treat ALS, SMA, DMD and other rare diseases.

With a focus on large molecules, the application and potential of gene therapy treatments in this field will be a focal point of the agenda, which features leading drug developers such as Biogen, Roche, Acceleron and PTC Therapeutics. Join us in October to see how this can help you to accelerate the development of your neuromuscular drug candidate.

Take a look at the agenda and register.

5th Annual Cell & Gene Therapy Congress 2019
Oxford Global is proud to present the 5th Annual Cell & Gene Therapy Congress, 29-30 October 2019 in London, UK. The Cell & Gene Therapy market has seen exponential growth and represents a substantial portion of the pharmaceutical industry. The congress brings together key speakers from leading Pharmaceutical companies and prestigious research institutions to explore insights into the challenges facing Cell & Gene therapy.

The congress will cover the development of cell & gene therapy and clinical trials, Bioprocessing and manufacturing strategies as well as commercialisation of treatments.

View the agenda.

Cell and Gene Therapy Manufacturing 2019
Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong. According to current market growth rates the industry will surpass $35 billion by 2026 and we want to know how your company is capitalising on this. New market conditions, lack of established development pathways and constantly evolving global regulatory requirements make the efficient manufacture of cell and gene therapies a challenging undertaking for any company.

We understand that these challenges require industry specific strategies, so we are bringing leading experts from the likes of the MHRA, BlueRock Therapeutics, Orchard Therapeutics, Celyad and Novo Nordisk at this year’s Cell and Gene Therapy Manufacturing Forum, 29-31 October 2019 in London, UK, to identify key strategies that will transform your manufacturing capabilities in the move towards commercialisation.

Register now.

- 20 - 22 August 2019, 2nd Annual Hemophilia Drug Development Summit - Gene Therapy Drugs, Boston, MA
- 9 - 12 September 2019, Cell & Gene Therapy Manufacturing and Commercialization, Boston, MA
- 10 - 13 September 2019, CAR-TCR Summit Boston 2019, Boston, MA
- 7 - 8 October 2019, 9th annual Partnership Opportunities in Drug Delivery, Boston, MA
- 9 October 2019, The Cell & Gene Therapy Strategy Meeting Europe, Zurich, Switzerland
- 15 – 16 October 2019, 9th Annual Orphan Drugs and Rare Diseases conference, London, UK
- 15 – 17 October 2019, Gene Therapy for Rare Disorders Europe 2019, London, UK
- 21 – 22 October 2019, NORD's 2019 Rare Diseases & Orphan Products Breakthrough Summit, Washington, D.C.
- 21 – 25 October 2019, XXVII Congress of the European Society of Gene and Cell Therapy (ESGCT), Barcelona, Spain
- 23 – 25 October 2019, Neuromuscular Drug Development Summit - Gene Therapies, Boston, MA
- 24 – 25 October 2019, 5th Annual Cell & Gene Therapy Congress, London, UK
- 29 – 31 October 2019, Cell and Gene Therapy Manufacturing Forum event, London, UK
- 19 – 20 November 2019, 3rd Annual Ophthalmic Drugs Conference - gene therapy for eye diseases, London, UK
- 12 - 15 May 2020, American Society of Gene and Cell Therapy (ASGCT) 23th Annual Meeting, Boston, MA
- 31 March - 2 April 2020, 15th Annual World Advanced Therapies Congress, London, UK
- 20 – 23 October 2019, XXVIII Congress of the European Society of Gene and Cell Therapy (ESGCT), Edinburgh UK


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?